Antineoplastic Agents TRIZ Cases
- Nutritional Supplement for Chemotherapy Sensitization
A nutritional supplement combining fish oil and selenium yeast reduces IL-6 expression to sensitize resistant tumor cells against chemotherapy side effects.
- Navitoclax Ruxolitinib Dosing for Myelofibrosis Spleen Reduction
Dual inhibition of JAK and BCL-2 pathways via specific dosing regimens overcomes resistance to monotherapy.
- Farnesyltransferase Inhibitor Treatment Stratification
CXCL12 biomarker profiling stratifies lymphoma patients for targeted farnesyltransferase inhibitor therapy, resolving variable treatment outcomes.
- Metallic Nanoparticles for Radiotherapy Without Cell Uptake
Metallic nanoparticles achieve therapeutic effects without cell uptake, reducing metal dosage and administration steps.
- CCR4 Modulators Block Treg Recruitment in EBV Cancers
CCR4 modulators block regulatory T cell recruitment to tumor sites.
- Dendronised Polymer Non-Viral Transfection Agent
Segmented PAMAM dendrons on linear backbones resolve cytotoxicity and packaging limits for CRISPR delivery.
- Mitochondrial Transcription Inhibitors for Cancer Therapy
Combining allosteric inhibitors of mitochondrial RNA polymerase with anti-cancer drugs overcomes metabolic heterogeneity and resistance mechanisms.
- Mercaptopurine-Modified miRNA Mimics for AML Treatment
Replacing adenine with 6-mercaptopurine in micro-RNA mimics reduces toxicity while maintaining efficacy against acute myeloid leukemia.
- Escherichia tRNA Fragments for Cancer Therapy
Double-stranded RNA fragments derived from Escherichia inhibit cancer cell growth and proliferation through antisense binding mechanisms.
- Microwave Extraction of Polysaccharides from Plant Residue
Microwave heating breaks cell wall bonds to release polysaccharides, overcoming low yield and high energy consumption.
- Vitamin B6 Mediator for FdUMP-TS Complex Stability
Pyridoxine expands intracellular folate pools to stabilize the FdUMP-thymidylate synthase complex, resolving limited antitumor efficacy.